Literature DB >> 28481558

Copper(I)-Catalyzed Stereo- and Chemoselective Borylative Radical Cyclization of Alkyl Halides Bearing an Alkene Moiety.

Hiroaki Iwamoto1, Sota Akiyama1, Keiichi Hayama1, Hajime Ito1.   

Abstract

The stereoselective borylative radical cyclization of alkyl halides containing an alkene moiety was developed using a copper(I)/diboron catalyst system. The optimized reaction conditions allowed us to control the chemoselectivity between the allylic substitution and the borylative radical cyclization. The borylation products were subsequently converted to highly functionalized organic compounds by derivatization of the newly formed C-B bond. This borylative radical cyclization offers a novel methodology for the stereoselective synthesis of various heterocyclic compounds.

Entities:  

Year:  2017        PMID: 28481558     DOI: 10.1021/acs.orglett.7b00940

Source DB:  PubMed          Journal:  Org Lett        ISSN: 1523-7052            Impact factor:   6.005


  5 in total

1.  Transition-Metal-Catalyzed 1,2-Carboboration of Alkenes: Strategies, Mechanisms, and Stereocontrol.

Authors:  Zhen Liu; Yang Gao; Tian Zeng; Keary M Engle
Journal:  Isr J Chem       Date:  2019-09-10       Impact factor: 3.333

2.  Cu-Catalyzed Decarboxylative Borylation.

Authors:  Jie Wang; Ming Shang; Helena Lundberg; Karla S Feu; Scott J Hecker; Tian Qin; Donna G Blackmond; Phil S Baran
Journal:  ACS Catal       Date:  2018-09-13       Impact factor: 13.084

Review 3.  New avenues for C-B bond formation via radical intermediates.

Authors:  Florian W Friese; Armido Studer
Journal:  Chem Sci       Date:  2019-09-03       Impact factor: 9.825

4.  Construction of congested Csp3-Csp3 bonds by a formal Ni-catalyzed alkylboration.

Authors:  Amit Kumar Simlandy; Stephen R Sardini; M Kevin Brown
Journal:  Chem Sci       Date:  2021-03-09       Impact factor: 9.825

5.  Deoxygenative Borylation of Secondary and Tertiary Alcohols.

Authors:  Florian W Friese; Armido Studer
Journal:  Angew Chem Int Ed Engl       Date:  2019-06-05       Impact factor: 15.336

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.